Afferent Pharmaceuticals Announces Phase 2 Clinical Trial with AF-219
November 11, 2015The trial will measure the effect of AF-219 compared to placebo in idiopathic pulmonary fibrosis patients (IPF) with cough and complements positive results from a recent phase 2 study in patients with chronic cough.
More »
FDA Accepts PMA Submission for ReVision Optics’ Raindrop Near Vision Inlay
November 10, 2015Raindrop is a microscopic hydrogel inlay designed to correct presbyopia. The FDA has made a threshold determination that the Raindrop PMA submission is sufficiently complete to move forward in the FDA review and approval process.
More »
aTyr Pharma Initiates Phase 1b/2 Clinical Trial in Patients with Early Onset FSHD
November 9, 2015aTyr announced the continued expansion of its Resolaris™ clinical program in rare myopathies with an immune component ("RMICs") by initiating a Phase 1b/2 clinical trial in patients with early onset facioscapulohumeral muscular dystrophy (FSHD.
More »